Eurofins MWG Operon Joins Roche NimbleGen, Inc's Certified Service Provider Program for Targeted Enrichment and Sequencing Services

MADISON, Wis.--(BUSINESS WIRE)--Roche NimbleGen (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY) is pleased to announce that Eurofins MWG Operon, an Ebersberg, Germany-based company, has officially become a Certified Service Provider (CSP) for NimbleGen Sequence Capture. They will provide services for NimbleGen Titanium Optimized Sequence Capture coupled with sequencing services from 454 Life Sciences, a Roche Company. Eurofins MWG Operon has passed a rigorous certification test plan to achieve precise experimental standards to officially become part of the Roche NimbleGen Certified Service Provider Program. Their certification marks the first genomic service provider to join the global Roche NimbleGen CSP Program in Europe. They will process customer gDNA samples for genomic enrichment using the complete NimbleGen Sequence Capture workflow optimized for 454 Titanium sequencing using 385K Arrays (capture of up to 5 Mb custom regions).